Storys aus Germany
-
Sprache:
Englisch
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
- mehr
Fraunhofer-Institut für Sichere Informationstechnologie SIT
AI against money laundering
mehrFraport Group’s Business Performance Improves Noticeably in the First Quarter of 2023
Frankfurt/Main, Germany (ots) - Operating result (EBITDA) more than doubles to €158.3 million – Full-year outlook confirmed – CEO Schulte: We’re heading in the right direction. Business boosted by passenger recovery in the first quarter Fraport successfully started the new 2023 business year, ...
Ein DokumentmehrBjörn Cochlovius New CEO of Eleva / Seasoned Molecular Biologist and Entrepreneur Leads German Biotech Company into its Next Development
Freiburg, Germany (ots) - Björn Cochlovius Ph.D. has become the new CEO of Eleva, a Freiburg-based biotech company and the developer of “Bryotechnology”, a unique and pioneering process for the moss-based production of complex therapeutic proteins. The renowned oncologist, immunologist, and molecular biologist ...
mehrNeuraxpharm agrees on the divestment of inhalation API specialist Inke to Keensight Capital
Barcelona, Spain, Düsseldorf, Germany and Paris (ots/PRNewswire) - Transaction enables Neuraxpharm to further focus on its core CNS therapeutic area and for Inke to accelerate its development as an independent entity Neuraxpharm Group ("Neuraxpharm"), the leading European specialty pharmaceutical company focused on ...
mehrGrünenthal and King’s College London collaborate to develop human induced pluripotent stem cell-based microfluidic cultures for pain research
Aachen, Germany and London, England (ots) - - Dr Ramin Raouf from King's College London and Grünenthal strive to develop reliable microfluidic culture models relevant for pain research based on human induced pluripotent stem cell-derived neurons - Grünenthal has expertise in developing human induced pluripotent ...
mehr- 2
ROVEMA invites confectionery and snack manufacturers to their Customized Experience in-house trade fair
mehr - 2
New measurement method: Cleaner traffic thanks to Big Data
mehr LTS Lohmann Therapie-Systeme AG
LTS expands into large molecule drug delivery with the acquisition of the Sorrel wearable injection device business
Andernach, Germany (ots) - LTS LOHMANN Therapie-Systeme AG (“LTS”), a leading pharmaceutical technology company that develops and manufactures innovative drug delivery systems such as Transdermal Patches (“TTS”), Oral Thin Films (“OTF”) and Micro Array Patches (“MAP”) announces the signing of the ...
mehrNTT DATA Business Solutions AG
2NTT DATA Business Solutions Receives four SAP® Pinnacle Awards 2023 and is a finalist in three categories
mehrDissolution of licence agreements in Germany: Avis-Budget loses station infrastructure in 7 of 16 German states
Hamburg, Germany (ots) - - Avis-Budget surprisingly terminates licensees - Station network in 7 of 16 German federal states becomes independent After 30 years of successful cooperation, Avis-Budget and the German licensee Wucherpfennig & Krohn will go their separate ways from 31. 12. 2023. The contract was ...
mehrDEKRA expands Board of Management / Petra Finke and Peter Laursen to fill newly created Board of Management positions at DEKRA
mehrProject TwinTrace: Customcells works together with partners on a smart battery factory
mehrChina-Germany (Shenyang) Equipment Manufacturing Industrial Park
Tiexi Day witnesses Sino-German Cooperation
mehrNTT DATA Business Solutions AG
2NTT DATA Business Solutions receives SAP S/4HANA® Cloud Partner of the Year award for 2023 Diamond Initiative for SAP Partners
mehrFocus on technological progress and sustainable future / Bertrandt launches new brand identity
mehrRecovery Continues: Fraport's 2022 Fiscal Year Marked by Strong Demand
Frankfurt/Main, Germany (ots) - Group result improves to EUR166.6 million - CEO Schulte expects continued traffic growth during summer by about 15 to 25 percent - Tighter climate targets for 2030: Fraport aims to cut carbon emissions by 78 percent compared to 1990 base-year Fraport AG's business ...
Ein DokumentmehrThe world's first Extended Isolated Stopflow Limb Infusion (EISLI) to treat osteosarcoma results in complete remission
mehrMadeira's public health service SESARAM, EPERAM cooperates with EU project Smart4Health
Potsdam (Germany) (ots) - - Over 260,000 residents and travelers to Madeira Islands can use the digital health solution free of charge - Easy access to healthcare data from the public healthcare services, via a European electronic health record - the Smart4Health platform The Public Health Service of the Autonomous Region of Madeira - SESARAM, EPERAM - has successfully ...
mehrACPS Automotive opens office in China
mehrBreakthrough - EUR 50 million investment for start-up BrainRepair UG / Pivotal trial on stem cell treatment for brain damage in newborns fully funded
mehrbiomindz Standortentwicklungsgesellschaft Mainz GmbH i.G.
Newly established company to promote Mainz as hub for life science and biotechnology now operational and supporting the city of Mainz
mehrVACUUMSCHMELZE (VAC) Announces Binding Supply Agreement with General Motors (GM) to Support EV Growth
mehrMPC Container Ships and INERATEC sign offtake agreement for sustainable marine diesel / E-fuel delivery for the shipping sector
Karlsruhe, Germany (ots) - MPC Container Ships (OSE: MPCC) and INERATEC have signed an agreement for the supply of synthetic Marine Diesel Oil (MDO) made from biogenic CO2 and renewable hydrogen, with delivery set to start in 2024. The shipping industry is undertaking great efforts to decarbonize and, due to its ...
mehrGerman Clean Tech company INERATEC secures investment from Honda and existing shareholders to support further growth
Karlsruhe, Germany (ots) - Best-in-class technology to meet global ambitions for sustainable fuels German Clean Tech company INERATEC, leader in the production of e-fuels, closes a new round with Honda Motor Co., Ltd. alongside existing shareholders Engie New Ventures, MPC, Safran Corporate Ventures, FO Holding, ...
mehrAnother very successful year for the ZEISS Group
mehrHearing loss company Acousia Therapeutics completes clinical Phase 1 study with its small molecule
Tübingen, Germany (ots) - Hearing loss company Acousia Therapeutics GmbH announced the successful completion of its ACOU085 clinical Phase 1b study today, following the final visit of the last patient treated with the highest ACOU085 dose. ACOU085 is a proprietary small-molecule drug candidate under clinical ...
mehrYanfeng’s new XiM23 redefines luxury for future mobility
mehrInternational Investment Forum (IIF)
IIF: Digital Investor Conference on December 7 – International Investment Forum
Hanover, Germany (ots) - For the 5th time, the International Investment Forum (IIF) will offer first-hand information for investors, live and via Zoom. We hereby invite to attend the 5th International Investment Forum (IIF) on December 7, 2022 starting at 10:00 am (CET) | 04.00 am (ET) all the day until 07:30 pm (CET) | 01:30 pm (ET). will present in 30-minute ...
mehrHearing loss company Acousia Therapeutics to present data for lead candidates ACOU085 & ACOU082 at ARO 2023 MidWinter Meeting February 11–15
Tübingen, Germany (ots) - Acousia Therapeutics GmbH, and its partners from the Translational Hearing Research Group at the Tübingen Hearing Research Center (Department of Otolaryngology, Head and Neck Surgery, University of Tübingen), will present data on its lead candidates — clinical stage ACOU085 and late ...
mehr